You are here:

Aktuelle Studien

Indikation: patients with septic shock and persistent tachycardia
Studienname: LANDI-SEP; EudraCT Nr 2017-002138-22

  • Phase IV, multicenter, prospective, randomized, open-labelcontrolled study on Landiolol in patients with septic shock resident in an Intensive Care Unit 
  • Link to details on Clinicaltrialsregister.eu

Indikation: supraventricular tachycardia in pediatric patients
Studienname: LANDI-PED; EudraCT Nr 2015-001129-17

  • A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in pediatric patients

Indikation: Polycythemia Vera
Studienname: CONTINUATION-PV; EudraCT Nr 2014-001357-17

  • An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously participated in the PROUD-PV study
  • Link to details on Clinicaltrials.gov